| (N)SCLC | (Non-)Small Cell Lung Cancer |
| 1-OHP | Oxaliplatin, trans-R,R-Cyclohexane-1,2-diamineoxalatoplatinum(II) |
| 9-HPbD | 9-Hydroxypheophorbide α |
| CBDCA | Carboplatin, cis-Diammine-1,1-cyclobutanedicarboxylatoplatinum(II) |
| CDDP | Cisplatin, cis-Diamminedichloridoplatinum(II) |
| CI | Combination Index |
| DCF | 2′,7′-Dichlorofluorescein |
| Fa | Fraction affected |
| FBS | Fetal Bovine Serum |
| GSH | Glutathione |
| H2DCF-DA | 2′,7′-Dichlorodihydrofluorescein Diacetate |
| LED | Light-emitting Diode |
| mTHPC | 5,10,15,20-tetra(m-Hydroxyphenyl)chlorin |
| MTT | 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium Bromide |
| PARP | Poly(ADP-Ribose) Polymerase |
| PBS | Phosphate Buffered Saline |
| PDT | Photodynamic Therapy |
| PI | Propidium Iodide |
| PTX | Paclitaxel |
| ROS | Reactive Oxygen Species |
| SDC | Solvent Dark Control |